Healthcare
Lenskart Solutions Ltd
LENSKART · NSE · INE956O01016Wednesday, 9 Sept 20261:31 pm
Market Cap₹1,20,578 Cr
P/E182.8
P/B13.8
EPS₹3.81
Div Yield—
ROE6.8%
ROCE5.8%
ROE6.8%
1Y Return+55.81%
Avg. Volume10.9M
Price Chart
52-Week Range
About
Lenskart Solutions Ltd is a Healthcare company listed on NSE.
Technicals
Free account
Register freeTechnicals
Create a free account to view momentum, moving averages, and delivery signals.
Quant
Premium
UpgradeQuant metrics
Upgrade to view volatility, drawdown, factor, and risk metrics.
Key Ratios
Market Cap₹1,20,578 Cr
Current Price₹696.4
52W High / Low₹703.5 / ₹356.1
Stock P/E182.8
Price to Book13.8
EPS (TTM)₹3.81
Dividend Yield—
ROE6.8%
1Y Return+55.81%
Day Change+0.09%
Profit & Loss
| Period | TTM | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|---|
| Sales | ₹9,634 Cr | ₹8,814 Cr | ₹6,653 Cr | |||||
| Expenses | ₹7,633 Cr | ₹7,060 Cr | ₹5,676 Cr | |||||
| Operating Profit | ₹2,000 Cr | ₹1,754 Cr | ₹977 Cr | |||||
| OPM % | 21.0% | 20.0% | 15.0% | |||||
| Other Income | ₹186 Cr | ₹153 Cr | ₹351 Cr | |||||
| Depreciation | ₹1,116 Cr | ₹1,048 Cr | ₹797 Cr | |||||
| Interest | ₹191 Cr | ₹178 Cr | ₹146 Cr | |||||
| Profit Before Tax | ₹880 Cr | ₹680 Cr | ₹385 Cr | |||||
| Tax | ₹212 Cr | ₹179 Cr | ₹88 Cr | |||||
| Net Profit | ₹668 Cr | ₹501 Cr | ₹297 Cr | |||||
| EPS (₹) | 4.4 | 2.8 | 3.8 | |||||
| Dividend Payout % | — | 0% | 0% |
Financial history locked
Register freeRegister free to see 5 more years.
Quarterly Results
| Quarter | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | ₹2,714 Cr | ₹2,516 Cr | ₹2,308 Cr | ₹2,096 Cr | ||||
| Expenses | ₹2,126 Cr | ₹1,979 Cr | ₹1,845 Cr | ₹1,683 Cr | ||||
| Operating Profit | ₹588 Cr | ₹536 Cr | ₹462 Cr | ₹413 Cr | ||||
| OPM % | 22.0% | 21.0% | 20.0% | 20.0% | ||||
| Depreciation | ₹305 Cr | ₹288 Cr | ₹270 Cr | ₹253 Cr | ||||
| Interest | ₹53 Cr | ₹44 Cr | ₹49 Cr | ₹45 Cr | ||||
| Net Profit | ₹228 Cr | ₹204 Cr | ₹133 Cr | ₹103 Cr | ||||
| EPS (₹) | 1.3 | 1.2 | 0.8 | 1.2 |
Quarterly history locked
Register freeRegister free to see 4 more quarters.
Balance Sheet
| Period | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹347 Cr | ₹154 Cr | ₹15 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹8,391 Cr | ₹5,777 Cr | ₹5,467 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹3,097 Cr | ₹2,740 Cr | ₹2,343 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹2,410 Cr | ₹1,719 Cr | ₹1,662 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹14,245 Cr | ₹10,390 Cr | ₹9,487 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹7,740 Cr | ₹6,231 Cr | ₹5,501 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹571 Cr | ₹1,038 Cr | ₹1,003 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹5,822 Cr | ₹3,014 Cr | ₹2,912 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹14,245 Cr | ₹10,390 Cr | ₹9,487 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet history locked
Register freeRegister free to see 5 more years.
Cash Flow
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| FY26 | ₹1,670 Cr | ₹-2,551 Cr | ₹1,201 Cr | ₹319 Cr |
| FY25 | ₹1,231 Cr | ₹-262 Cr | ₹-535 Cr | ₹434 Cr |
| FY24 | ₹487 Cr | ₹163 Cr | ₹-722 Cr | ₹-72 Cr |
| FY23 | ||||
| FY22 | ||||
| FY21 | ||||
| FY20 |
Cash flow history locked
Register freeRegister free to see 5 more years.
Peer Comparison
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Dr. Agarwals Health Care Ltd | ₹16,351 Cr | 111.4 | +8.63% | +3.15% |
| Fabtech Technologies Ltd | ₹656 Cr | 13.5 | +12.5% | -21.51% |
| Fischer Medical Ventures Ltd | — | — | +8.59% | -10.66% |
| Inventurus Knowledge Solutions Ltd | ₹29,900 Cr | 39.8 | +31.46% | +7.00% |
| Indegene Ltd | — | — | +14.4% | +14.54% |
Mutual Fund Holdings
Free account
Register freeMutual fund holdings
Create a free account to see institutional ownership snapshots.
Bulk & Block Deals
Free account
Register freeBulk & block deals
Create a free account to view recent institutional deal activity.
Analyst Estimates
Free account
Register freeAnalyst estimates
Create a free account to view analyst estimate summaries.
Latest News
2026-08-27Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE Filing2026-08-17Lenskart Solutions Ltd (NSE:LENSKART) (Q1 2027) Earnings Call Highlights: PAT Surges 182% as ...GuruFocus.com2026-06-03Lenskart Solutions Ltd (NSE:LENSKART) Q4 2026 Earnings Call Highlights: Record Revenue Growth ...GuruFocus.com
Documents & Filings
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.